Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from MedTech

2 Recession-Proof Dividend Stocks to Buy for the Second Half of 2025

These blue-chip stocks offer a rare combination of stability, resilience, and moderate growth.

Barchart

Johnson & Johnson Credits Tariff Delays For Strong Earnings, While Jim Cramer Pegs It On 'Lower Than Thought' Levies

Johnson Johnson (NYSE:JNJ) delivered better-than-expected second quarter results, with the management hinting at leveraging tariff delays to maintain its outlook; however, CNBC’s Jim Cramer credited the performance to lower tariffs.

Benzinga

Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance

Johnson Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy?

Johnson & Johnson had more good than bad; investors should look at the entire report in context before deciding if JNJ stock is a good fit for their portfolios

MarketBeat

3 Dividend Stocks to Buy for a Safe Haven in This Volatile Market

The consistency in their dividend payments makes them dependable stocks in a volatile market.

Barchart

Resilient Investing: 3 Stocks Built to Weather Market Volatility

Resilient companies with strong financials and diverse revenue in healthcare, technology, and essential services can offer stability in volatile markets.

MarketBeat

Is Johnson & Johnson Stock Underperforming the Dow?

Despite Johnson & Johnson’s underperformance relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

2 Dividend Kings You Should Snap Up Immediately

Recent earnings from these dividend-paying companies reflects their stability.

Barchart

This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here.

This weight-loss underdog doubled in a single day last week and could deliver even bigger rewards.

Barchart

Dr. LEVY Switzerland The ThermoGlow Pro review: salon-quality home facials for firmer, clearer, younger-looking skin

Get your glow on with the biohacking skincare device that cleanses, purifies and revitalises

3 MedTech Stocks to Grab Now for a Strong 2025

This article highlights three MedTech stocks poised for growth in 2025

Barchart

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Benzinga

3 Blue-Chip Stocks to Anchor Your Portfolio

Amid ongoing uncertainties surrounding the economy and global power dynamics, market volatility continues to dominate. In such times, investing in fundamentally sound blue-chip stocks, Johnson & Johnson (JNJ), American Express (AXP), and AT&T (T), could offer investors a stable foundation, serving as a buffer against market fluctuations and uncertainty. Read…

StockNews.com

Becton, Dickinson and Company Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Becton, Dickinson and Company’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stryker Stock Outlook: Is Wall Street Bullish or Bearish?

Medtech giant Stryker has outperformed the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.

StockNews.com

3 MedTech Stocks to Watch as Innovation in Healthcare Soars

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in digital health technologies. Thus, adding strong MedTech stocks like Becton, Dickinson (BDX), Abbott (ABT), and Medtronic (MDT) to your watchlist could be wise as innovation in healthcare accelerates. Read more….

Barchart

Is Apple Stock a Buy for MedTech Upside?

The FDA recently approved two key features of popular Apple devices.

StockNews.com

3 MedTech Stocks Revolutionizing Healthcare

MedTech stocks are at the forefront of revolutionizing healthcare with the dynamic growth potential of technology. Amid this backdrop, it could be wise to consider investing in companies like Medtronic (MDT), STERIS (STE), and Hologic (HOLX), which are transforming the way healthcare is delivered and tailoring it to individual patient…

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

How High Can This Healthcare Stock Soar With Nvidia's Help?

Dividend King J&J can boost its MedTech business with Nvidia’s help.

StockNews.com

3 High-Growth MedTech Stocks to Buy

The medtech industry’s long-term growth is fueled by growing demand for medical devices, adoption of cutting-edge technologies, and improved efficiency. Thus, it could be ideal to buy fundamentally solid medtech stocks Baxter International (BAX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC) poised for substantial growth. Keep reading.

StockNews.com

3 MedTech Stocks Innovating Healthcare

MedTech’s bright future is fueled by rapid tech advancements and increasing demand for medical devices, implants, and precision treatments, driven by an aging population and rising global disease rates. Given this backdrop, adding strong MedTech stocks like Boston Scientific (BSX), Stryker (SYK), and Abbott (ABT) to one’s portfolio could be…

StockNews.com

3 MedTech Stocks to Add to Your Portfolio in July

The MedTech sector’s promising future is driven by technological advances, unceasing demand for medical treatments due to an aging population, and increasing global incidence of diseases. To that end, strong MedTech stocks such as Tactile Systems Technology (TCMD), Electromed (ELMD), and Embecta (EMBC) could be wise portfolio additions in July.…

International Business Times

How Medtech Companies Are Unlocking The Potential Of Latin America In Clinical Research

In 2020, there were 67 medical device trials in Latin America, a 67.5% increase from 40 in 2017.

International Business Times UK

New MedTech Funding To Predict Diseases And Make Treatments Available To UK Patients

The UK government has awarded medtech funding to eight UK medtech companies which are developing pathbreaking tests and AI detection tools for faster treatment of life-threatening diseases, reducing the burden of NHS.

Investors Business Daily

Stock Market Continues To Rally; ASML, Netflix, Tesla, Intel Are Big Earnings Movers: Weekly Review

The market rally continued amid near-perfect economic data. ASML and Netflix were earning winners. Tesla and Intel dived on guidance.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.